According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal.
The report cites unnamed sources who said the settlement would be one of the highest ever in a drug marketing case.
Federal law says drug makers can market medicines only for uses approved by the U.S. ...
continue reading...